Cost-Effectiveness Evaluation of Medical Therapies

This session highlights cost-effectiveness evaluations of a broad range of therapies for physcial and mental health conditions. Using trial-based economic evaluations and Markov models, these evaluations studied cognitive behavioral therapy after brain injury, pharmacological treatment for active lupus nephritis and transthyretin amyloid cardiomyopathy, and antipsychotic long-acting injectables.

Code

100